Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 8, Number 6, June 2016, pages 431-436


Associations of Apolipoprotein A, High-Sensitivity C-Reactive Protein and Fasting Plasma Insulin in Obese Children With and Without Family History of Cardiovascular Disease

Figure

Figure 1.
Figure 1. Relation of HOMA with IR (r = 0.998, P < 0.001).

Tables

Table 1. Basic Characteristics Between Boys and Girls (n = 68)
 
Boys (N = 28), mean ± SDGirls (N = 40), mean ± SDP-value
P < 0.05. aMann-Whitney test, all other t-test.
Age (years)9.78 ± 3.489.48 ± 2.710.684
Height (cm)1.41 ± 0.191.39 ± 0.150.479
Weight (kg)a50.2 ± 26.443 ± 21.90.223
BMI (kg/m2)a23.67 ± 7.421.2 ± 6.60.182
SBP (mm Hg)59.72 ± 7.850.3 ± 29.20.185
DBP (mm Hg)57.32 ± 8.849.2 ± 25.40.224
TC (mg/dL)a162.4 ± 45.5162.8 ± 29.70.974
TG (mg/dL)a78.5 ± 39.583.9 ± 450.605
HDL (mg/dL)a48.3 ± 14.752.3 ± 16.80.307
LDL (mg/dL)92 ± 24.195 ± 22.80.543
ApoA (mg/dL)133.53 ± 0140.3 ± 27.10.330
ApoB (mg/dL)a69.9 ± 22.263.6 ± 15.10.165

 

Table 2. Comparison of Normal and Obese Groups With and Without FH of CVD
 
VariablesNormalObese
PFH (n = 8)NFH (n = 25)Total (n = 33)PFH (n = 15)NFH (n = 20)Total (n = 35)
P < 0.05. aDistribution not normal (median, min. - max.). bData presented as log (geometric mean × geometric SD). *Statistically significant difference between obese and normal group. **Statistically significant difference between obese and normal group with PFH.
SBP54 ± 23.938.9 ± 26.642.5 ± 26.468.5 ± 24.963.2 ± 28.265.5 ± 26.6*
DBP47.5 ± 30.151.2 ± 30.450.3 ± 29.953.3 ± 29.956 ± 19.954.9 ± 24.3
TC167 ± 33166 ± 30167 ± 31191 ± 18178 ± 24181 ± 24.5*
TG59.5 ± 22.573.8 ± 42.270.4 ± 38.788 ± 44.595.9 ± 44.292.5 ± 43.8*
HDL64.9 ± 19.354.4 ± 17.556.9 ± 18.241.9 ± 1046.5 ± 10.644.5 ± 10.5*
LDL88.8 ± 29.592 ± 43.490.4 ± 40.6104.4 ± 2199.5 ± 23101 ± 22.9
ApoA159.9 ± 25141 ± 31.6145.6 ± 31135.4 ± 21.8**121 ± 23.6129 ± 23.3*
ApoB61 ± 15.667.3 ± 19.365.9 ± 18.566.6 ± 22.866.7 ± 15.966.7 ± 18.9
Lp(a)a20 (3.4 - 113.9)21.2 (2 - 200)21.2 (2 - 200)16.5 (4.1 - 106)16.5 (4.4 - 87)16.5 (4.1 - 106)
hsCRPa0.11 (0.01 - 2.54)0.08 (0.01 - 2.6)0.08 (0.01 - 2.6)0.78 (0.03 - 2.8)0.73 (0.02 - 2.7)0.75 (0.02 - 2.8)*
FBG84.4 ± 1288 ± 7.787 ± 8.987 ± 8.789.5 ± 888.4 ± 8.4
FPIa6.6 (1.1 - 35.6)8.6 (2.9 - 159)8.2 (1.1 - 159)16 (4.5 - 42)**11.8 (0.2 - 31)12.8 (0.2 - 42)*
HOMA-IRb0.95 × 2.28 (0.35 - 4.35)1.06 × 1.68 (0.38 - 3.24)1.03 × 1.81 (0.35 - 4.35)1.8 × 1.9 (0.58 - 5.24)1.43 × 1.77 (0.37 - 3.83)1.58 × 1.83* (0.37 - 5.24)

 

Table 3. Univariate Logistic Regression Analysis Between Cardiometabolic Risk Factor and Family History of CVD
 
Univariate logistic regression results*
OR95% CIP-valueSensitivity/specificity
*P < 0.05.
SBP (mm Hg)1.0180.999 - 1.0370.0640.13/0.93
TC (mg/dL)1.9831.965 - 2.0010.0700.13/0.96
TG (mg/dL)0.9970.985 - 1.0090.6240.00/1.00
HDL (mg/dL)0.9960.965 - 1.0280.8010.00/1.00
ApoA (mg/dL)0.9950.978 - 1.0130.6030.00/1.00
hsCRP1.3670.689 - 2.7150.3710.00/1.00
FPI (mIU/mL)1.0580.993 - 1.1270.0800.17/0.94
HOMA-IR1.5700.941 - 2.6190.0840.17/0.94

 

Table 4. Logistic Regression Analysis Between Cardiometabolic Risk Factor and Obesity
 
Multivariate logistic regression analysis
OR95% CIP-valueSensitivity/specificity
*P < 0.05.
SBP (mm Hg)1.0451.016 - 1.0740.002*0.13/0.93
TC (mg/dL)1.9651.935 - 2.9700.031*0.13/0.96
TG (mg/dL)0.9970.985 - 1.0090.6240.00/1.00
HDL (mg/dL)0.9960.965 - 1.0280.8010.00/1.00
ApoA (mg/dL)0.9950.978 - 1.0130.6030.00/1.00
hsCRP2.920.966 - 8.8280.0580.00/1.00
FPI (mIU/mL)1.0580.993 - 1.1270.0800.17/0.94
HOMA-IR1.5700.941 - 2.6190.0840.17/0.94